{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:31:46Z","timestamp":1787938306749,"version":"build-2784847793"},"reference-count":25,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.vaccine.2024.126209","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T09:15:17Z","timestamp":1725095717000},"page":"126209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Persistence of immunity in children aged 2\u00a0months and 7\u00a0months \u2013 5\u00a0years old after primary immunization with 13-valent pneumococcal conjugate vaccine"],"prefix":"10.1016","volume":"42","author":[{"given":"Guifan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126209_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/1469-0691.12461","article-title":"Pneumococcal infection in adults: burden of disease","volume":"20","author":"Drijkoningen","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2024.126209_bb0010","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunization-WHO position paper","volume":"82","author":"World Health Organization","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2024.126209_bb0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.126209_bb0020","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2024.126209_bb0025","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/00006454-200111000-00004","article-title":"Pneumococcal carriage in children during their first two years: important role of family exposure","volume":"20","author":"Leino","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.126209_bb0030","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1128\/JCM.39.9.3316-3320.2001","article-title":"Pneumococcal carriage in children in the Netherlands: a molecular epidemiological study","volume":"39","author":"Bogaert","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2024.126209_bb0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1086\/431524","article-title":"Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study","volume":"192","author":"Goldblatt","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126209_bb0040","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/503805","article-title":"Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease","volume":"193","author":"Hammitt","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126209_bb0045","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1086\/652443","article-title":"Transmission of Streptococcus pneumoniae in rural gambian villages: a longitudinal study","volume":"50","author":"Hill","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126209_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00937-20","article-title":"A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral streptococcus","volume":"11","author":"Ganaie","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2024.126209_bb0055","first-page":"309","article-title":"Review: current and new generation pneumococcal vaccines","volume":"69","author":"Feldman","year":"2014","journal-title":"J Inf Secur"},{"key":"10.1016\/j.vaccine.2024.126209_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14712598.2018.1384462","article-title":"Development of pneumococcal vaccines over the last 10 years","volume":"18","author":"Principi","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2024.126209_bb0065","first-page":"258","article-title":"Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep 2010"},{"key":"10.1016\/j.vaccine.2024.126209_bb0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126209_bb0075","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1016\/j.vaccine.2021.09.047","article-title":"A phase 3 clinical trial of MINHAI PCV13 in Chinese children aged from 7 months to 5 years old","volume":"39","author":"Liang","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126209_bb0080","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2021.2019498","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered in a prime-boost regimen among Chinese infants: a randomized, double blind phase III clinical trial","volume":"18","author":"Wang","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.126209_bb0085","first-page":"514","article-title":"Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides","volume":"10","author":"Wernette","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2024.126209_bb0090","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies","volume":"25","author":"Siber","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126209_bb0095","first-page":"308","article-title":"Centers for Disease Control and Prevention (CDC). Progress in introduction of pneumococcal conjugate vaccine - worldwide, 2000-2012","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.126209_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000348","article-title":"Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project","volume":"7","author":"Johnson","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2024.126209_bb0105","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/CVI.00039-13","article-title":"Concentration and high avidity of pneumococcal antibodies persist at least 4 years after immunization with pneumococcal conjugate vaccine in infancy","volume":"20","author":"Ekstr\u00f6m","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2024.126209_bb0110","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/thoraxjnl-2019-213878","article-title":"Persistence of immunity in children immunised with 13-valent pneumococcal conjugate vaccine and impact on nasopharyngeal carriage: a cross-sectional study","volume":"75","author":"Janapatla","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2024.126209_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091413","article-title":"Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial","volume":"9","author":"Tr\u00fcck","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.126209_bb0120","first-page":"1","article-title":"Prevention of pneumococcal disease among infants and children-use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine-recommendations of the advisory committee on immunization practices (ACIP)","volume":"59","author":"Nuorti","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2024.126209_bb0125","series-title":"Replacement of technical report series no. 927, annex 2, ECBS","article-title":"Recommendations to assure the quality, safety and efficacy of pneumococcal conjugate vaccines","author":"World Health Organization","year":"2013"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24008910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24008910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T17:55:37Z","timestamp":1729014937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24008910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":25,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0264410X24008910"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126209","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistence of immunity in children aged 2\u00a0months and 7\u00a0months \u2013 5\u00a0years old after primary immunization with 13-valent pneumococcal conjugate vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126209"}}